Post by The Florey

It is with deep sadness that we share news of the passing of Dr Hugh Niall AO. Hugh was scientific figure of rare stature, one whose influence on Australian biotechnology, and on the translation of discovery science into medicines, was both profound and enduring. From the outset, Hugh's intellectual range set him apart. His early work at St Vincent’s Institute of Medical Research placed him at the leading edge of protein chemistry, and later in the US, at the National Institutes of Health and Harvard Medical School, he refined and extended the techniques that would make modern protein science possible. Hugh’s determination of the structures of key human hormones was not simply a technical achievement; it was foundational work that enabled the development of therapies for significant diseases and established him as one of the foremost protein chemists of his generation. It was at The Florey, however, that Hugh’s impact on Australian science was most deeply felt. As Associate Director, Hugh helped shape the Institute during a formative period, contributing not only scientific leadership but a broader vision of what Australian biomedical research could be. He later extended that influence onto the global stage and played a central role in guiding programs that would lead to therapies now used worldwide. Yet Hugh’s commitment to Australian science remained constant, and he returned home in the mid-1990s with a determination to strengthen the local biotechnology sector, which he did through roles at Biota Holdings, Avexa and the Australian Stem Cell Centre. Hugh is survived by his children, Lucy, Jake, Ben and Emma. His legacy endures in the strength of Australian biotechnology, in the global impact of the medicines he helped bring into being, and in the work of the many researchers that he inspired. Vale Dr Hugh David Niall AO | 15 August 1937 – 11 April 2026 Read more: https://lnkd.in/gDtpa2eF For funeral details, please visit: https://lnkd.in/gXGgQ5qi